Literature DB >> 21944270

Acute changes in blood glucose do not alter blood glutathione synthesis in adolescents with poorly controlled type 1 diabetes mellitus.

Dominique Darmaun1, Susan Welch, Shiela Smith, Shawn Sweeten, Nelly Mauras.   

Abstract

Depletion of blood glutathione (GSH), a key antioxidant, is associated with type 1 diabetes mellitus (T1D) and contributes to the pathophysiology of diabetes complications. The aim of the current study was to determine whether acute normalization of blood glucose would restore GSH kinetics in adolescents with poorly controlled T1D. Ten 16.9 ± 1.5-year-old (SE) adolescents who had had T1D for 8.5 ± 1.9 years and were free of complications but were in poor control (hemoglobin A(1c), 9.2% ± 0.5%) received two 5-hour intravenous infusions of L-[3,3-(2)H(2)]cysteine in the postabsorptive state on 2 separate days after blood glucose had been maintained overnight at 246 ± 24 mg/dL (hyperglycemia) or 118 ± 23 mg/dL (euglycemia) using intravenous insulin infusion. Blood GSH fractional synthesis rates were determined by mass spectrometry from (2)H(2)-cysteine incorporation into GSH. Neither blood GSH (551 ± 169 vs 541 ± 232 μmol/L, P = .629) nor GSH fractional synthesis rate (84% ± 30% vs 82% ± 33% d(-1), P = .965) was altered by the short-term change in glycemic control. This finding suggests that, in adolescents with poorly controlled T1D, either (a) blood glucose per se does not regulate GSH metabolism or (b) GSH may only respond to sustained, more chronic changes in blood glucose level. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944270     DOI: 10.1016/j.metabol.2011.07.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  1 in total

1.  Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia.

Authors:  Fallon K Lutchmansingh; Jean W Hsu; Franklyn I Bennett; Asha V Badaloo; Norma McFarlane-Anderson; Georgiana M Gordon-Strachan; Rosemarie A Wright-Pascoe; Farook Jahoor; Michael S Boyne
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.